0000950170-23-070396.txt : 20231214 0000950170-23-070396.hdr.sgml : 20231214 20231214161512 ACCESSION NUMBER: 0000950170-23-070396 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231212 FILED AS OF DATE: 20231214 DATE AS OF CHANGE: 20231214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: White William Richard CENTRAL INDEX KEY: 0001778739 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39438 FILM NUMBER: 231487240 MAIL ADDRESS: STREET 1: C/O AKERO THERAPEUTICS, INC. STREET 2: 170 HARBOR WAY 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Disc Medicine, Inc. CENTRAL INDEX KEY: 0001816736 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851613057 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 321 ARSENAL STREET, SUITE 101 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: (617) 674-9274 MAIL ADDRESS: STREET 1: 321 ARSENAL STREET, SUITE 101 CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: Gemini Therapeutics, Inc. /DE DATE OF NAME CHANGE: 20210209 FORMER COMPANY: FORMER CONFORMED NAME: FS Development Corp. DATE OF NAME CHANGE: 20200702 4 1 ownership.xml 4 X0508 4 2023-12-12 0001816736 Disc Medicine, Inc. IRON 0001778739 White William Richard C/O DISC MEDICINE, INC. 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 true false false false false Common Stock 2023-12-12 4 M false 21084 2.65 A 21084 D Common Stock 2023-12-12 4 M false 5427 9.86 A 26511 D Common Stock 2023-12-12 4 M false 7000 13.50 A 33511 D Common Stock 2023-12-12 4 S false 12100 59.4392 D 21411 D Common Stock 2023-12-12 4 S false 1091 63.7324 D 20320 D Common Stock 2023-12-12 4 S false 16263 65.2611 D 4057 D Common Stock 2023-12-12 4 S false 4057 66.0959 D 0 D Stock Option (Right to Buy) 2.65 2023-12-12 4 M false 21084 0.00 D 2030-11-26 Common Stock 21084 7024 D Stock Option (Right to Buy) 9.86 2023-12-12 4 M false 5427 0.00 D 2031-09-13 Common Stock 5427 4216 D Stock Option (Right to Buy) 13.50 2023-12-12 4 M false 7000 0.00 D 2032-12-28 Common Stock 7000 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.6974, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (4) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.51 to $63.883, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.995, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.00 to $66.3684, inclusive. The shares underlying this option vest in 16 equal quarterly installments following November 27, 2020, subject to the Reporting Person's continued service on each such vesting date. The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date. The shares underlying this option are fully vested and exercisable as of the date hereof. By: /s/ Rahul Khara, as Attorney-in-Fact 2023-12-14